Abstract P6-12-02: SYD985, a novel anti-HER2 ADC, shows promising activity in patients with HER2-positive and HER2-negative metastatic breast cancer
Authors
Aftimos, Pvan Herpen, C
Mommers, E
Koper, N
Goedings, P
Oesterholt, M
Awada, A
Desar, I
Lim, J
Dean, Emma J
Rolfo, C
Macpherson, I
Banerji, U
Affiliation
Institut Jules Bordet, Universite Libre de Broxelles, BrusselsIssue Date
2017-02-14
Metadata
Show full item recordCitation
Abstract P6-12-02: SYD985, a novel anti-HER2 ADC, shows promising activity in patients with HER2-positive and HER2-negative metastatic breast cancer 2017, 77 (4 Supplement):P6-12-02 Cancer ResearchJournal
Cancer ResearchDOI
10.1158/1538-7445.SABCS16-P6-12-02Type
Meetings and ProceedingsLanguage
enISSN
0008-54721538-7445
ae974a485f413a2113503eed53cd6c53
10.1158/1538-7445.SABCS16-P6-12-02